Annual Drug Patent Expirations for KINEVAC
Kinevac is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
Drug patent litigation for KINEVAC.
This drug has ten patent family members in eight countries.
The generic ingredient in KINEVAC is sincalide. One supplier is listed for this compound. Additional details are available on the sincalide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
